You have 9 free searches left this month | for more free features.

Anemia,%20Aplastic

Showing 1 - 25 of 2,357

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ATGAM General Investigation

Not yet recruiting
  • Aplastic Anemia
  • Anti-human thymocyte immunoglobulin, equine
  • (no location specified)
Sep 8, 2023

Aplastic Anemia, Platelet Transfusion Refractoriness Trial in Tianjin (Daratumumab)

Recruiting
  • Aplastic Anemia
  • Platelet Transfusion Refractoriness
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Apr 25, 2023

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

Severe Aplastic Anemia Trial in Tianjin (Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag)

Recruiting
  • Severe Aplastic Anemia
  • Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Jul 27, 2023

Non Severe Aplastic Anemia Trial in Beijing (Romiplostim, Ciclosporin)

Not yet recruiting
  • Non Severe Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 18, 2023

Non-severe Aplastic Anemia Trial (Trappa ethanolamine tablets ; ciclosporin, Placebo ; ciclosporin)

Not yet recruiting
  • Non-severe Aplastic Anemia
  • Trappa ethanolamine tablets ; ciclosporin
  • Placebo ; ciclosporin
  • (no location specified)
Mar 22, 2023

Severe Aplastic Anemia Trial in Tianjin (avatrombopag)

Recruiting
  • Severe Aplastic Anemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Feb 7, 2023

Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

Terminated
  • Refractory Aplastic Anemia
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 25, 2022

Non Severe Aplastic Anemia, Untreated Trial in China (Herombopag)

Recruiting
  • Non Severe Aplastic Anemia
  • Untreated
  • Tangshan, Hebei, China
  • +3 more
Dec 14, 2022

Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Severe Aplastic Anemia (SAA) Trial (Romiplostim, Antithymocyte Globulin, Cyclosporine A)

Not yet recruiting
  • Severe Aplastic Anemia (SAA)
  • (no location specified)
Sep 2, 2022

Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

Not yet recruiting
  • Aplastic Anemia
  • Drug Effect
  • Herombopag + CsA
  • rhTPO combined with Herombopag + CsA
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)

Recruiting
  • Severe Aplastic Anemia
  • Hetrombopag Olamine+Standard Therapy
  • Placebo+Standard Therapy
  • Tianjin, Tianjin, China
    Blood Diseases Hospital, Chinese Academy of Medical Sciences
Jul 28, 2022

s of AMG531 (Romiplostim) in Untreated Aplastic Anemia

Enrolling by invitation
  • Aplastic Anemia
    • Kanazawa, Ishikawa Prefecture, Japan
      Kanazawa University, College of Medical Pharmaceutical and Healt
    Aug 18, 2022

    Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)

    Not yet recruiting
    • Idiopathic Aplastic Anemia
    • +2 more
    • HSCT Arm group
    • (no location specified)
    Jun 10, 2022

    Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

    Recruiting
    • Aplastic Anemia
    • +2 more
    • Beijing, China
      Peking union medical college hospital
    Aug 20, 2023

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)

    Recruiting
    • Aplastic Anemia
    • Expanded autologous T regulatory cells
    • London, United Kingdom
      King's College Hospital
    Aug 16, 2022

    Aplastic Anemia Trial in Shinagawa (Romiplostim)

    Completed
    • Aplastic Anemia
    • Shinagawa, Tokyo, Japan
      NTT Medical center Tokyo
    May 25, 2022

    Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

    Recruiting
    • Aplastic Anemia
    • Bone Marrow Failure Syndrome
    • Anti-Thymocyte Globulin (Rabbit)
    • +8 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 26, 2022

    Aplastic Anemia Trial in Beijing (Luspatercept)

    Not yet recruiting
    • Aplastic Anemia
    • Beijing, China
      Peking union medical college hospital
    May 30, 2022